Literature DB >> 22158430

IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

J Silke, J E Vince.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22158430      PMCID: PMC3252841          DOI: 10.1038/cdd.2011.166

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  89 in total

1.  Is caspase 1 central to activation of interleukin-1?

Authors:  Miriam Wittmann; Sarah R Kingsbury; Michael F McDermott
Journal:  Joint Bone Spine       Date:  2011-04-03       Impact factor: 4.929

2.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

3.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

4.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.

Authors:  Fumiyo Ikeda; Yonathan Lissanu Deribe; Sigrid S Skånland; Benjamin Stieglitz; Caroline Grabbe; Mirita Franz-Wachtel; Sjoerd J L van Wijk; Panchali Goswami; Vanja Nagy; Janos Terzic; Fuminori Tokunaga; Ariadne Androulidaki; Tomoko Nakagawa; Manolis Pasparakis; Kazuhiro Iwai; John P Sundberg; Liliana Schaefer; Katrin Rittinger; Boris Macek; Ivan Dikic
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

Review 5.  Mitochondria: Sovereign of inflammation?

Authors:  Jürg Tschopp
Journal:  Eur J Immunol       Date:  2011-05       Impact factor: 5.532

6.  TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.

Authors:  A Phillip West; Igor E Brodsky; Christoph Rahner; Dong Kyun Woo; Hediye Erdjument-Bromage; Paul Tempst; Matthew C Walsh; Yongwon Choi; Gerald S Shadel; Sankar Ghosh
Journal:  Nature       Date:  2011-04-28       Impact factor: 49.962

7.  Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis.

Authors:  Andrew Oberst; Christopher P Dillon; Ricardo Weinlich; Laura L McCormick; Patrick Fitzgerald; Cristina Pop; Razq Hakem; Guy S Salvesen; Douglas R Green
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

8.  Mechanisms of necroptosis in T cells.

Authors:  Irene L Ch'en; Jennifer S Tsau; Jeffery D Molkentin; Masaaki Komatsu; Stephen M Hedrick
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

9.  Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).

Authors:  Ariel C Bulua; Anna Simon; Ravikanth Maddipati; Martin Pelletier; Heiyoung Park; Kye-Young Kim; Michael N Sack; Daniel L Kastner; Richard M Siegel
Journal:  J Exp Med       Date:  2011-01-31       Impact factor: 14.307

10.  RIP3 mediates the embryonic lethality of caspase-8-deficient mice.

Authors:  William J Kaiser; Jason W Upton; Alyssa B Long; Devon Livingston-Rosanoff; Lisa P Daley-Bauer; Razqallah Hakem; Tamara Caspary; Edward S Mocarski
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

View more
  2 in total

Review 1.  Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond.

Authors:  Junxia Zhang; Dairu Liu; Mao Zhang; Yan Zhang
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

2.  Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB.

Authors:  Vasilisa Aksenova; Lidia Turoverova; Mikhail Khotin; Karl-Eric Magnusson; Eugene Tulchinsky; Gerry Melino; George P Pinaev; Nickolai Barlev; Dmitri Tentler
Journal:  Oncotarget       Date:  2013-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.